Annotation Detail for CADM3
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04514 | Cell adhesion molecules (CAMs) |
Pathway ID | Pathway Name |
---|
| Cell junction organization |
Pathway ID | Pathway Name |
---|
500121 | Nectin/Necl trans heterodimerization |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of CADM3 mRNA | affects expression | 17484886
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of CADM3 mRNA | affects expression | 19590694
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CADM3 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.57 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.77 | 17306315 16712894 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
4.00 | 19015723 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.43 | 16192424 18705752 10355542 15700767 16097048 15673190 16050911 16227642 3786805 15721981 16011737 16124888 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.22 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.22 | 17306315 16507464 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.47 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.28 | 19524636 20056578 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.93 | 14966744 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
2.13 | 6623471 10915739 15998439 4309450 3732212 17522070 19336974 16227642 7120509 19085960 16177239 15968718 11566570 9327722 7440962 10092053 3786805 6884620 15027814 2869522 7179309 21278145 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.65 | 17595544 12795759 16045604 19224547 16239168 61145 15959796 12631006 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
4.10 | 18705752 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.68 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
6.17 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.42 | 16452187 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
4.18 | 19900420 19110552 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.56 | 12676792 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
5.27 | 16899240 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.74 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.79 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.79 | 16467254 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
3.02 | 20008137 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.47 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
3.02 | 16943688 16221502 11408273 16239168 11903743 17174718 21278145 17334410 17157831 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
1.75 | 17698563 18429990 17565644 18412020 18277467 18418968 15931870 15818738 17922224 12666154 16638106 15673190 18472094 18205269 16116963 13678700 18006644 17805973 14748882 16015684 18317297 17557913 17481882 16027843 16011737 18210741 16136751 12632514 12649538 14620537 18472332 10355542 17976157 14512876 17869086 17714472 15925388 18251166 18263696 18156304 12389079 16248980 15959796 17640975 15052691 12546737 12609069 15338365 17766677 12898905 18395095 12445421 11481614 18054572 15123356 18395914 12741479 12445418 18420326 15876570 12586293 18279442 16097048 14716496 14724832 17823541 12958196 12667390 15996030 15370692 15650968 17761835 18705752 15730626 15057751 17708605 15893842 18376398 17944888 17721639 14716833 17525996 16033810 12632512 17900296 16192424 17631135 18481824 18166357 15362042 18339082 18187930 20821823 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.16 | 15720792 15830285 16246199 17285989 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.82 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
4.14 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
5.08 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
5.08 | 15276417 16712894 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
2.86 | 12014681 15583823 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.45 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 16712894 17077188 19931552 17306315 15276417 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.68 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.32 | 20056578 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.41 | 12854658 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.54 | 15276417 17306315 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.64 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.68 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.23 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.68 | 18629315 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.87 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.14 | 12854658 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.64 | 17306315 11723127 16712894 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.21 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
5.17 | 17056641 |
PharmGKB Accession:PA162380906
Releated disease ID |
Related disease Name |
PA443250 | Acquired Immunodeficiency Syndrome |